🚀_老虎社区_美港股上老虎

NRN
2021-12-30

🚀

FDA Grants Emergency Use Nod to Siemens Healthineers' Covid-19 Rapid Antigen Self-Test

Siemens Healthineers(OTCPK:SMMNY)announces that the FDA has granted Emergency Use Authorization (EUA

FDA Grants Emergency Use Nod to Siemens Healthineers' Covid-19 Rapid Antigen Self-Test

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

暂无评论

热议股票

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":692369056,"tweetId":"692369056","gmtCreate":1640850829369,"gmtModify":1640850829789,"author":{"id":3563581390514944,"idStr":"3563581390514944","authorId":3563581390514944,"authorIdStr":"3563581390514944","name":"NRN","avatar":"https://static.tigerbbs.com/3561ad0f76bae7ec1e64062bc70f0207","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":42,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>🚀</p></body></html>","htmlText":"<html><head></head><body><p>🚀</p></body></html>","text":"🚀","highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/692369056","repostId":1171905604,"repostType":4,"repost":{"id":"1171905604","kind":"news","pubTimestamp":1640850704,"share":"https://www.laohu8.com/m/news/1171905604?lang=&edition=full","pubTime":"2021-12-30 15:51","market":"us","language":"en","title":"FDA Grants Emergency Use Nod to Siemens Healthineers' Covid-19 Rapid Antigen Self-Test","url":"https://stock-news.laohu8.com/highlight/detail?id=1171905604","media":"seekingalpha","summary":"Siemens Healthineers(OTCPK:SMMNY)announces that the FDA has granted Emergency Use Authorization (EUA","content":"<html><head></head><body><p>Siemens Healthineers(OTCPK:SMMNY)announces that the FDA has granted Emergency Use Authorization (EUA) for the CLINITEST Rapid COVID-19 Antigen Self-Test for unsupervised SARS-CoV-2testing by individuals age 14 and older (or adult-collected samples from individuals ages 2-13).</p><p>The easy-to-use nasal swab test provides visually read test results in just 15 minutes.</p><p>The test is expected to be available starting in January. Siemens Healthineers has secured dedicated production capacity for U.S. bound product in the tens of millions per month.</p><p>The EUA decision is based on the company&#39;s participation in the NIH Rapid Acceleration of Diagnostics’ (RADx) Independent Test Assessment Program.</p></body></html>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>FDA Grants Emergency Use Nod to Siemens Healthineers' Covid-19 Rapid Antigen Self-Test</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFDA Grants Emergency Use Nod to Siemens Healthineers' Covid-19 Rapid Antigen Self-Test\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-30 15:51 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3784061-fda-grants-emergency-use-nod-to-siemens-healthineers-covid-19-rapid-antigen-self-test><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Siemens Healthineers(OTCPK:SMMNY)announces that the FDA has granted Emergency Use Authorization (EUA) for the CLINITEST Rapid COVID-19 Antigen Self-Test for unsupervised SARS-CoV-2testing by ...</p>\n\n<a href=\"https://seekingalpha.com/news/3784061-fda-grants-emergency-use-nod-to-siemens-healthineers-covid-19-rapid-antigen-self-test\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SMMNY":"Siemens Healthineers AG"},"source_url":"https://seekingalpha.com/news/3784061-fda-grants-emergency-use-nod-to-siemens-healthineers-covid-19-rapid-antigen-self-test","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1171905604","content_text":"Siemens Healthineers(OTCPK:SMMNY)announces that the FDA has granted Emergency Use Authorization (EUA) for the CLINITEST Rapid COVID-19 Antigen Self-Test for unsupervised SARS-CoV-2testing by individuals age 14 and older (or adult-collected samples from individuals ages 2-13).The easy-to-use nasal swab test provides visually read test results in just 15 minutes.The test is expected to be available starting in January. Siemens Healthineers has secured dedicated production capacity for U.S. bound product in the tens of millions per month.The EUA decision is based on the company's participation in the NIH Rapid Acceleration of Diagnostics’ (RADx) Independent Test Assessment Program.","news_type":1},"isVote":1,"tweetType":1,"viewCount":998,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":2,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"hasMoreComment":false,"orderType":2}

FDA Grants Emergency Use Nod to Siemens Healthineers' Covid-19 Rapid Antigen Self-Test

评论（2）

热议股票